| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cranial Irradiation | 6 | 2021 | 72 | 1.830 |
Why?
|
| Radiation Exposure | 3 | 2024 | 49 | 1.590 |
Why?
|
| Radiation Injuries, Experimental | 4 | 2017 | 23 | 1.500 |
Why?
|
| Bone Marrow | 3 | 2017 | 332 | 1.340 |
Why?
|
| Glioma | 6 | 2019 | 534 | 1.060 |
Why?
|
| Brain Neoplasms | 10 | 2019 | 1407 | 1.000 |
Why?
|
| Rats | 21 | 2021 | 3623 | 0.930 |
Why?
|
| Leukocytes | 6 | 2024 | 210 | 0.920 |
Why?
|
| Radiation Protection | 3 | 2022 | 57 | 0.860 |
Why?
|
| Brain | 12 | 2021 | 3196 | 0.760 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 55 | 0.680 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2019 | 1224 | 0.650 |
Why?
|
| Radiation Injuries | 2 | 2022 | 158 | 0.640 |
Why?
|
| Hematologic Tests | 1 | 2019 | 37 | 0.640 |
Why?
|
| Encephalitis | 1 | 2020 | 118 | 0.630 |
Why?
|
| Neurogenesis | 3 | 2022 | 221 | 0.620 |
Why?
|
| Blood Chemical Analysis | 1 | 2019 | 87 | 0.620 |
Why?
|
| Animals | 49 | 2024 | 35064 | 0.610 |
Why?
|
| Multimodal Imaging | 2 | 2017 | 113 | 0.600 |
Why?
|
| Behavior, Animal | 1 | 2020 | 507 | 0.560 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 578 | 0.560 |
Why?
|
| Mannans | 1 | 2017 | 15 | 0.550 |
Why?
|
| Bystander Effect | 1 | 2017 | 6 | 0.540 |
Why?
|
| Wound Healing | 2 | 2014 | 480 | 0.540 |
Why?
|
| Prebiotics | 1 | 2017 | 28 | 0.540 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 84 | 0.530 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2018 | 134 | 0.520 |
Why?
|
| Cell Proliferation | 5 | 2020 | 2511 | 0.510 |
Why?
|
| Neurotransmitter Agents | 1 | 2017 | 144 | 0.510 |
Why?
|
| Microcirculation | 6 | 2006 | 115 | 0.510 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 78 | 0.500 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 169 | 0.480 |
Why?
|
| Dideoxynucleosides | 1 | 2015 | 10 | 0.480 |
Why?
|
| Machine Learning | 1 | 2019 | 345 | 0.480 |
Why?
|
| Blood-Brain Barrier | 5 | 2011 | 157 | 0.470 |
Why?
|
| Body Weight | 3 | 2016 | 1009 | 0.470 |
Why?
|
| Ferrosoferric Oxide | 1 | 2015 | 28 | 0.470 |
Why?
|
| Hippocampus | 3 | 2022 | 819 | 0.460 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 41 | 0.460 |
Why?
|
| Allergens | 1 | 2017 | 277 | 0.460 |
Why?
|
| Mechanical Phenomena | 1 | 2014 | 16 | 0.450 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2020 | 666 | 0.450 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 422 | 0.440 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 237 | 0.440 |
Why?
|
| Growth Disorders | 1 | 2016 | 222 | 0.440 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 4675 | 0.430 |
Why?
|
| Cognition Disorders | 1 | 2018 | 571 | 0.420 |
Why?
|
| Mice | 26 | 2024 | 18572 | 0.400 |
Why?
|
| Radiation Dosage | 4 | 2024 | 145 | 0.400 |
Why?
|
| Male | 31 | 2024 | 64891 | 0.340 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2009 | 123 | 0.340 |
Why?
|
| Whole-Body Irradiation | 2 | 2024 | 60 | 0.330 |
Why?
|
| Skin Physiological Phenomena | 1 | 2010 | 17 | 0.330 |
Why?
|
| Gliosis | 3 | 2020 | 33 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 4756 | 0.330 |
Why?
|
| Asthma | 1 | 2017 | 770 | 0.320 |
Why?
|
| Fluorescein-5-isothiocyanate | 4 | 2009 | 28 | 0.310 |
Why?
|
| Ependymoma | 2 | 2008 | 176 | 0.300 |
Why?
|
| Radiation Tolerance | 3 | 2018 | 64 | 0.300 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2021 | 254 | 0.280 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 175 | 0.280 |
Why?
|
| Rats, Wistar | 3 | 2017 | 328 | 0.270 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 295 | 0.260 |
Why?
|
| Models, Biological | 2 | 2010 | 1464 | 0.260 |
Why?
|
| Microfilament Proteins | 2 | 2020 | 287 | 0.260 |
Why?
|
| Ellagic Acid | 3 | 2010 | 4 | 0.240 |
Why?
|
| Abdominal Injuries | 1 | 2006 | 117 | 0.240 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2007 | 614 | 0.240 |
Why?
|
| Chitosan | 3 | 2010 | 31 | 0.230 |
Why?
|
| Sirolimus | 1 | 2006 | 239 | 0.230 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 337 | 0.220 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 703 | 0.220 |
Why?
|
| Blood Cell Count | 1 | 2024 | 69 | 0.210 |
Why?
|
| Hyperinsulinism | 1 | 2024 | 64 | 0.210 |
Why?
|
| Time Factors | 6 | 2019 | 6411 | 0.210 |
Why?
|
| Craniotomy | 1 | 2004 | 105 | 0.210 |
Why?
|
| Oxygen | 2 | 2007 | 566 | 0.210 |
Why?
|
| Cytokines | 2 | 2008 | 1367 | 0.200 |
Why?
|
| Microscopy | 1 | 2004 | 125 | 0.200 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 14 | 0.190 |
Why?
|
| Insulin-Secreting Cells | 1 | 2024 | 147 | 0.190 |
Why?
|
| RNA, Long Noncoding | 1 | 2025 | 241 | 0.190 |
Why?
|
| Adaptation, Physiological | 2 | 2021 | 278 | 0.180 |
Why?
|
| Biomechanical Phenomena | 2 | 2014 | 260 | 0.180 |
Why?
|
| Cell Death | 2 | 2020 | 246 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3847 | 0.180 |
Why?
|
| Astronauts | 1 | 2022 | 76 | 0.180 |
Why?
|
| Dose-Response Relationship, Radiation | 4 | 2017 | 68 | 0.180 |
Why?
|
| Protons | 1 | 2021 | 97 | 0.180 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2020 | 33 | 0.170 |
Why?
|
| Neoplasm Transplantation | 3 | 2017 | 383 | 0.170 |
Why?
|
| Cyclohexanones | 1 | 2020 | 17 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 33 | 0.170 |
Why?
|
| HMGB1 Protein | 1 | 2020 | 25 | 0.170 |
Why?
|
| Malignant Hyperthermia | 1 | 2020 | 19 | 0.170 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2020 | 121 | 0.170 |
Why?
|
| Endothelium, Vascular | 4 | 2011 | 486 | 0.170 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 119 | 0.170 |
Why?
|
| Interferon-beta | 3 | 2010 | 54 | 0.170 |
Why?
|
| Chloride Channels | 1 | 2020 | 63 | 0.170 |
Why?
|
| Apoptosis | 3 | 2020 | 1900 | 0.170 |
Why?
|
| Thermogenesis | 1 | 2020 | 50 | 0.170 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2020 | 115 | 0.170 |
Why?
|
| Metabolic Syndrome | 1 | 2024 | 365 | 0.160 |
Why?
|
| Ventricular Remodeling | 1 | 2020 | 165 | 0.160 |
Why?
|
| Random Allocation | 1 | 2020 | 431 | 0.160 |
Why?
|
| Muscle, Skeletal | 2 | 2004 | 1033 | 0.160 |
Why?
|
| Receptors, Steroid | 1 | 2020 | 203 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2012 | 443 | 0.160 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 333 | 0.150 |
Why?
|
| Pyridines | 1 | 2020 | 247 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 258 | 0.150 |
Why?
|
| Space Flight | 1 | 2022 | 170 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2021 | 300 | 0.150 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2020 | 241 | 0.140 |
Why?
|
| Rats, Inbred F344 | 1 | 2018 | 97 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 237 | 0.140 |
Why?
|
| Radiotherapy Dosage | 2 | 2017 | 232 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2017 | 2 | 0.140 |
Why?
|
| Taurine | 1 | 2017 | 11 | 0.140 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 26 | 0.140 |
Why?
|
| Airway Remodeling | 1 | 2017 | 21 | 0.140 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 759 | 0.140 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 73 | 0.130 |
Why?
|
| Drug Delivery Systems | 3 | 2010 | 226 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 140 | 0.130 |
Why?
|
| Positron-Emission Tomography | 2 | 2018 | 308 | 0.130 |
Why?
|
| Cognition | 3 | 2022 | 809 | 0.130 |
Why?
|
| Bone Neoplasms | 2 | 2021 | 445 | 0.130 |
Why?
|
| Muscle, Smooth | 1 | 2017 | 129 | 0.130 |
Why?
|
| Sarcoma, Ewing | 1 | 2018 | 116 | 0.130 |
Why?
|
| Allografts | 1 | 2017 | 195 | 0.130 |
Why?
|
| Venules | 2 | 2013 | 28 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2017 | 172 | 0.130 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 693 | 0.130 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 845 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 297 | 0.120 |
Why?
|
| X-Rays | 1 | 2015 | 30 | 0.120 |
Why?
|
| Magnetics | 1 | 2015 | 37 | 0.120 |
Why?
|
| Peptide Hormones | 1 | 2016 | 71 | 0.120 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 1359 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 421 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 458 | 0.120 |
Why?
|
| Astrocytes | 2 | 2009 | 270 | 0.110 |
Why?
|
| Cell Adhesion | 7 | 2011 | 327 | 0.110 |
Why?
|
| Algorithms | 3 | 2019 | 1713 | 0.110 |
Why?
|
| Kinetics | 1 | 2017 | 1213 | 0.110 |
Why?
|
| Fasting | 1 | 2016 | 308 | 0.110 |
Why?
|
| Humans | 25 | 2025 | 132045 | 0.110 |
Why?
|
| Platelet Count | 1 | 2014 | 139 | 0.110 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1025 | 0.110 |
Why?
|
| Mesocricetus | 3 | 2003 | 74 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 67 | 0.110 |
Why?
|
| Cell Line, Tumor | 8 | 2018 | 3700 | 0.110 |
Why?
|
| Quinic Acid | 1 | 2013 | 2 | 0.110 |
Why?
|
| Radiation-Protective Agents | 1 | 2013 | 19 | 0.110 |
Why?
|
| Cricetinae | 3 | 2003 | 386 | 0.110 |
Why?
|
| Age Factors | 1 | 2020 | 2921 | 0.110 |
Why?
|
| Cell Communication | 3 | 2021 | 187 | 0.110 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 52 | 0.100 |
Why?
|
| Biopsy | 1 | 2017 | 1287 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1410 | 0.100 |
Why?
|
| Inflammation | 2 | 2020 | 1521 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 1055 | 0.100 |
Why?
|
| Vascular System Injuries | 1 | 2013 | 60 | 0.100 |
Why?
|
| Tumor Burden | 2 | 2011 | 249 | 0.100 |
Why?
|
| Nanoshells | 1 | 2012 | 13 | 0.100 |
Why?
|
| Oxygen Consumption | 2 | 2010 | 296 | 0.090 |
Why?
|
| Osteoblasts | 1 | 2013 | 162 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2013 | 145 | 0.090 |
Why?
|
| Phototherapy | 1 | 2012 | 39 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2016 | 801 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 217 | 0.090 |
Why?
|
| Hyperthermia, Induced | 1 | 2012 | 58 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2015 | 512 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2462 | 0.090 |
Why?
|
| Skin | 1 | 2014 | 540 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2010 | 873 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 2153 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2014 | 1539 | 0.090 |
Why?
|
| Dextrans | 3 | 2009 | 47 | 0.090 |
Why?
|
| Radiotherapy, Conformal | 2 | 2008 | 63 | 0.090 |
Why?
|
| Camptothecin | 1 | 2010 | 74 | 0.080 |
Why?
|
| Recombinant Proteins | 5 | 2016 | 1383 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2010 | 25 | 0.080 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2010 | 31 | 0.080 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 22 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 618 | 0.080 |
Why?
|
| Glycerophosphates | 1 | 2010 | 3 | 0.080 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 104 | 0.080 |
Why?
|
| Finite Element Analysis | 1 | 2010 | 36 | 0.080 |
Why?
|
| Anisotropy | 1 | 2010 | 126 | 0.080 |
Why?
|
| Elasticity | 1 | 2010 | 92 | 0.080 |
Why?
|
| Fibrin | 1 | 2010 | 64 | 0.080 |
Why?
|
| Endothelial Cells | 3 | 2012 | 525 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1875 | 0.080 |
Why?
|
| Gels | 1 | 2010 | 72 | 0.080 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 1 | 2010 | 40 | 0.080 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 174 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 304 | 0.080 |
Why?
|
| Antibodies | 2 | 2016 | 367 | 0.080 |
Why?
|
| Models, Animal | 2 | 2011 | 470 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 125 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2684 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2025 | 2710 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 226 | 0.070 |
Why?
|
| Arterioles | 2 | 2009 | 29 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2008 | 212 | 0.070 |
Why?
|
| Receptors, Collagen | 1 | 2007 | 7 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2010 | 596 | 0.070 |
Why?
|
| Tight Junctions | 2 | 2004 | 40 | 0.070 |
Why?
|
| Capillary Permeability | 2 | 2006 | 76 | 0.070 |
Why?
|
| Tensile Strength | 1 | 2006 | 45 | 0.060 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 30 | 0.060 |
Why?
|
| Cell Wall | 1 | 2006 | 40 | 0.060 |
Why?
|
| Osteogenesis | 2 | 2021 | 163 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2008 | 1007 | 0.060 |
Why?
|
| Mutation | 1 | 2020 | 6250 | 0.060 |
Why?
|
| Female | 9 | 2021 | 70672 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2020 | 880 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1391 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2010 | 717 | 0.060 |
Why?
|
| Insulin | 2 | 2024 | 1219 | 0.060 |
Why?
|
| E-Selectin | 1 | 2005 | 39 | 0.060 |
Why?
|
| P-Selectin | 1 | 2005 | 68 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 287 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2013 | 1191 | 0.060 |
Why?
|
| Ribonuclease III | 1 | 2025 | 98 | 0.060 |
Why?
|
| Pia Mater | 1 | 2004 | 10 | 0.050 |
Why?
|
| Spermatic Cord | 1 | 2004 | 12 | 0.050 |
Why?
|
| Proinsulin | 1 | 2024 | 13 | 0.050 |
Why?
|
| Rhodamines | 1 | 2004 | 22 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2006 | 276 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2025 | 146 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2003 | 434 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3869 | 0.050 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 303 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2007 | 348 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 72 | 0.050 |
Why?
|
| Osteocalcin | 1 | 2024 | 46 | 0.050 |
Why?
|
| Glucagon | 1 | 2024 | 174 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2006 | 413 | 0.050 |
Why?
|
| Mice, SCID | 3 | 2010 | 606 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2005 | 880 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2005 | 274 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2024 | 137 | 0.050 |
Why?
|
| Abdominal Muscles | 1 | 2003 | 28 | 0.050 |
Why?
|
| Guanidines | 1 | 2003 | 23 | 0.050 |
Why?
|
| Base Sequence | 2 | 2007 | 2986 | 0.050 |
Why?
|
| Biological Availability | 1 | 2003 | 150 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2578 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.050 |
Why?
|
| Acetylcholine | 1 | 2003 | 84 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2003 | 91 | 0.050 |
Why?
|
| Gene Expression | 2 | 2007 | 1567 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2003 | 171 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 672 | 0.050 |
Why?
|
| Radiation, Ionizing | 3 | 2010 | 42 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 242 | 0.050 |
Why?
|
| Thrombosis | 1 | 2007 | 525 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2003 | 223 | 0.050 |
Why?
|
| Vasodilation | 1 | 2003 | 176 | 0.050 |
Why?
|
| Melanoma | 1 | 2009 | 953 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2002 | 142 | 0.050 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 13 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 234 | 0.040 |
Why?
|
| Gap Junctions | 1 | 2021 | 45 | 0.040 |
Why?
|
| Weight Gain | 1 | 2024 | 408 | 0.040 |
Why?
|
| Astrocytoma | 1 | 2002 | 111 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 67 | 0.040 |
Why?
|
| Infant | 3 | 2020 | 13112 | 0.040 |
Why?
|
| Clonal Evolution | 1 | 2021 | 49 | 0.040 |
Why?
|
| Heart Function Tests | 1 | 2020 | 53 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 46 | 0.040 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 31 | 0.040 |
Why?
|
| Heat-Shock Response | 1 | 2020 | 37 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 217 | 0.040 |
Why?
|
| Lactates | 1 | 2020 | 101 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2020 | 14821 | 0.040 |
Why?
|
| Restraint, Physical | 1 | 2000 | 26 | 0.040 |
Why?
|
| Hypothalamus | 1 | 2002 | 211 | 0.040 |
Why?
|
| Permeability | 2 | 2011 | 127 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 1000 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 85 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 367 | 0.040 |
Why?
|
| Child | 5 | 2020 | 25779 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2010 | 38 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 396 | 0.040 |
Why?
|
| Muramidase | 2 | 2010 | 92 | 0.040 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 272 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2010 | 136 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 424 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 683 | 0.040 |
Why?
|
| Leukocyte Rolling | 2 | 2011 | 4 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2025 | 917 | 0.040 |
Why?
|
| Adolescent | 3 | 2020 | 20513 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 67 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 2069 | 0.030 |
Why?
|
| Cell Survival | 2 | 2010 | 866 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 557 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2010 | 1039 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 2485 | 0.030 |
Why?
|
| Progeria | 1 | 2016 | 17 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2009 | 757 | 0.030 |
Why?
|
| Macrophages | 1 | 2020 | 694 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 76 | 0.030 |
Why?
|
| Fibrillin-1 | 1 | 2016 | 62 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 664 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1528 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 198 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2016 | 92 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2016 | 233 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 157 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 447 | 0.030 |
Why?
|
| Hypoxia | 2 | 2007 | 260 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 505 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 619 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 893 | 0.030 |
Why?
|
| Microspheres | 2 | 2005 | 73 | 0.030 |
Why?
|
| Blood Cells | 1 | 2013 | 56 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 285 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 257 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 153 | 0.030 |
Why?
|
| Peptides | 2 | 2007 | 846 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1983 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2007 | 1722 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 283 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 62 | 0.020 |
Why?
|
| Neoplasms | 1 | 2007 | 2942 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 263 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 77 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 2696 | 0.020 |
Why?
|
| Glucose | 1 | 2016 | 906 | 0.020 |
Why?
|
| Biotransformation | 1 | 2010 | 56 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2016 | 3834 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 159 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 56 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2012 | 250 | 0.020 |
Why?
|
| Baculoviridae | 1 | 2010 | 63 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2010 | 26 | 0.020 |
Why?
|
| Joints | 1 | 2010 | 26 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2010 | 33 | 0.020 |
Why?
|
| Rheology | 1 | 2010 | 34 | 0.020 |
Why?
|
| Solutions | 1 | 2010 | 60 | 0.020 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2010 | 28 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2010 | 147 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 101 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2010 | 33 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2010 | 80 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2009 | 105 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 139 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 111 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2009 | 201 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 249 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 425 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4724 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1804 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2010 | 492 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 617 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2007 | 26 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2007 | 38 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 987 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2007 | 41 | 0.020 |
Why?
|
| Chlorides | 1 | 2007 | 104 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2007 | 26 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2007 | 37 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2007 | 107 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2009 | 1079 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2007 | 123 | 0.020 |
Why?
|
| Phosphorylcholine | 1 | 2006 | 25 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2006 | 23 | 0.020 |
Why?
|
| Gram-Positive Bacteria | 1 | 2006 | 48 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2006 | 55 | 0.020 |
Why?
|
| Neurons | 2 | 2007 | 2028 | 0.020 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2009 | 215 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 239 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 638 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 9934 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 381 | 0.020 |
Why?
|
| Dependovirus | 1 | 2007 | 153 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2010 | 557 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2006 | 265 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 745 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 775 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2007 | 435 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 772 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2007 | 378 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2006 | 380 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 2757 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2006 | 469 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17307 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2006 | 638 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 1758 | 0.010 |
Why?
|
| Physical Phenomena | 1 | 2000 | 3 | 0.010 |
Why?
|
| Physics | 1 | 2000 | 8 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 3060 | 0.010 |
Why?
|
| Hematocrit | 1 | 2000 | 116 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28827 | 0.010 |
Why?
|
| Linear Models | 1 | 2002 | 714 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 31576 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 141 | 0.010 |
Why?
|
| Radiography | 1 | 2000 | 812 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2002 | 373 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1826 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 8501 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 6509 | 0.010 |
Why?
|